UNITY Biotechnology Total Liabilities 1970-1969 | UBX

UNITY Biotechnology total liabilities from 1970 to 1969. Total liabilities can be defined as the total value of all possible claims against the corporation.

UNITY Biotechnology Total Liabilities 1970-1969 | UBX

UNITY Biotechnology total liabilities from 1970 to 1969. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$231.3B
Amgen (AMGN)$162.4B
Gilead Sciences (GILD)$142.4B
Vertex Pharmaceuticals (VRTX)$121.3B
Bristol Myers Squibb (BMY)$92.4B
CSL (CSLLY)$84B
GSK (GSK)$76.9B
Regeneron Pharmaceuticals (REGN)$61.7B
Alnylam Pharmaceuticals (ALNY)$55B
Argenex SE (ARGX)$42.2B
BioNTech SE (BNTX)$26.5B
Royalty Pharma (RPRX)$21.3B
Insmed (INSM)$21.1B
Biogen (BIIB)$19.4B
Incyte (INCY)$15.2B
Illumina (ILMN)$15.1B
Genmab (GNMSF)$14.7B
Genmab (GMAB)$14.1B
BioMarin Pharmaceutical (BMRN)$11.6B
Ascendis Pharma (ASND)$11.3B
QIAGEN (QGEN)$11.2B
Moderna (MRNA)$10.8B
Swedish Orphan Biovitrum (BIOVF)$10.6B
Exelixis (EXEL)$9.9B
Verona Pharma American Depositary Share (VRNA)$9B
Exact Sciences (EXAS)$8.8B
Bio-Techne Corp (TECH)$8.6B
Blueprint Medicines (BPMC)$8.3B
Roivant Sciences (ROIV)$7.8B
Halozyme Therapeutics (HALO)$7.4B